The chemotherapeutic drug Taxol is known to interact within a specific site on ␤-tubulin. Although the general location of the site has been defined by photoaffinity labeling and electron crystallography, the original data were insufficient to make an absolute determination of the bound conformation. We have now correlated the crystallographic density with analysis of Taxol conformations and have found the unique solution to be a T-shaped Taxol structure. This T-shaped or butterfly structure is optimized within the ␤-tubulin site and exhibits functional similarity to a portion of the B9-B10 loop in the ␣-tubulin subunit. The model provides structural rationalization for a sizeable body of Taxol structureactivity relationship data, including binding affinity, photoaffinity labeling, and acquired mutation in human cancer cells.
T axol 1a [paclitaxel (PTX)] and Taxotere 1b (docetaxel) are important antitumor agents used clinically in the treatment of refractory ovarian cancer, small-cell lung cancer, metastatic breast disease, and other manifestations of the affliction (1) . The drugs are believed to block cell-cycle progression during mitosis by binding to and stabilizing microtubules (MTs) (2, 3) . One functional taxoid-binding site per tubulin (TB) dimer (4, 5) has been located on the ␤-subunit (6-11). The recently determined 3.7-Å structure of the ␣␤-TB-PTX complex (12) , obtained by electron crystallography (EC) of zinc-induced TB sheets, clearly shows the location of the binding site but lacks the resolution to completely determine the ligand conformation. Therefore, in the original report, the x-ray crystal structure of Taxotere (13) served as a PTX surrogate. More recently, the EC crystal structure of TB has been docked into a 20-Å map of the MT to provide a high-resolution model of this polymer (14) . The excellent fit indicates the similarity of the TB conformation in MTs and zinc-induced sheets. In the present work, we integrate the electron-density map of the refined complex and a three-step modeling strategy to define the PTX-binding conformation in the EC structure.
Methods
Conformational Selection and Fitting. Taxol combines a polar and rigid tetracyclic core with an equally polar set of four flexible side chains, containing 10 single bonds that contribute to the conformational flexibility of the molecule. Here we have explicitly considered 26 PTX conformers derived from x-ray crystal structures and from NMR nuclear Overhauser effect data of PTX and its derivatives (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) and a large number of computergenerated conformers. The individual conformers were docked into the experimental density map of the TB-PTX complex. Examples are portrayed in Fig. 1 . Most of the conformations leave the terminal C-13 phenyl rings in regions completely devoid of density. Two of these are shown in Fig. 1 a and b. On the other hand, three very similar conformations, two from the solid state (15, 16) and one from solution (24) , gave reasonable fits. One of the former was used as a starting point for further refinement of the TB-PTX complex (Fig. 1c) .
Stepped Optimization. Coordinates used for optimization were obtained by refinement ¶ of those placed on deposit at the Brookhaven Protein Data Bank (1TUB.pdb). Results of restricted low-temperature dynamics and force-field optimization were monitored for fit within the experimental density. Details are published as supplemental data on the PNAS web site (www.pnas.org).
Automated Docking. To certify that the T-or butterfly-binding motif is both unique and reproducible, PTX was removed from its protein complex, conformationally altered, and flexibly redocked into the binding pocket by using standard DOCK methodology (ref. 25 ; http:͞͞www.cmpharm.ucsf.edu͞kuntz͞ kuntz.html). Although many partially docked PTX structures were generated, only two conformers were encased by the protein. The lowest energy form is identical in shape and location to that in Fig. 3 . The other was scored 45 kcal͞mol higher in energy and involves a torsional exchange of C-3Ј phenyl and C-3Ј NHCOPh. In this orientation, the side chains fall clearly outside the EC density, ruling out the alternative conformation. No other binding mode within the ligand groove was identified. A second docking experiment with FlexX, a fragment-based flexible docking algorithm (ref. 26 ; http:͞͞cartan.gmd.de͞flexx͞), generated 200 PTX conformers. T-Taxol was docked twice. The orientation is shown in Figs. 3 and 4a as the lowest energy form. Scoring data are given in the supplementary material.
Discussion
Analysis of Taxol Conformation. There have been many speculations as to the bioactive conformation of PTX complexed with MTs. Initially, the nonpolar conformer, with the C-2 and C-3Ј phenyl side chains exhibiting hydrophobic collapse (Fig. 2a) , was proposed as the bioactive one (17) (18) (19) . Shortly thereafter, however, several laboratories argued in favor of the polar form (20) (21) (22) that juxtaposes the C-2 and C-3Ј benzamido side chains (Fig. 2b) (27) . More recently, during the processing of this manuscript, a pharmacophore model (28) and two studies using PTX docked into EC ␤-TB appeared, which also favor the polar structure (29, 30) . The binding conformation derived from the present analysis belongs to neither extreme. As illustrated by Fig.  2c , PTX's bound state in our model is characterized by the C-2 benzoyl phenyl, nearly equidistant from both of the phenyl rings emanating from C-3Ј in T-Taxol. A recent gas-phase ab initio conformational analysis of the PTX C-13 side chain led to a similar binding proposal (31) , underscoring the notion that low-energy experimental conformational minima are prime candidates for protein-bound small molecules (32) . The ligand structure corresponds to one member of the family of low population conformers found by NMR deconvolution analysis in chloroform (24) and DMSO͞water (J.P.S., N. Nevins, J. Jiménez-Barbero, D. Cicero, and J. M. Jansen, unpublished work). With T-Taxol nestled in the EC density of the computationally refined PTX-TB complex, residue His-229 of the protein is interposed between the PTX C-3Ј and C-2 phenyl rings, preventing their hydrophobic collapse (Figs. 3 and 4a) . The same observation with respect to C-2 has been made in connection with 2-m-azido baccatin III (33) . In association with ␤-TB, each of PTX's hydrophobic centers engages in complementary interactions with the protein (Fig. 4a ) rather than self, as in the polar and nonpolar conformations. This picture predicts that taxoid design and synthesis based on a hydrophobically collapsed motif are likely to lead to inactive compounds. The point has been made decisively in one completely inactive series in which Georg, Himes, and coworkers tethered the C-3Ј and C-2 phenyls with several two-atom spacers (34) .
Binding-Site Interactions. In our model, the binding pocket for PTX resides in a deep hydrophobic cleft near the surface of ␤-TB, where it interacts with the protein by means of three potential hydrogen bonds and multiple hydrophobic contacts. Importantly, the walls of the pocket are composed of several elements of secondary structure linked by the PTX molecule. Segments of helices H1, H6, H7, and the loop between H6 and H7 are anchored by hydrophobic interactions with PTX's 3Ј-benzamido phenyl, the 3Ј-phenyl, and the 2-benzoyl phenyl (Fig.  4a ). In addition, the 3Ј-phenyl enjoys close contacts with ␤-sheet strands B8 and B10. The refined site model suggests that a backbone NH of the loop connecting strands B9 and B10 is hydrogen bonded to 2Ј-OH. The C-4 acetate is situated above a 10-residue hydrophobic basin [Leu-230, Ala-233 (H7); Phe-272, Pro-274, CH 3 of Thr-276, Leu-286, Leu-291 (M-loop); Pro-360, Leu-371 (B9-B10 loop); and CH 2 of Ser-374 (B10)], half of which derives from the N-terminal end of the long meandering loop that connects B7 and H9, the M-loop (14) . The C-8 methyl is directed toward the M-loop, putting it in van der Waals contact with two residues near the C-terminal end, Thr-276 and Gln-281. The ligand's O-21 appears to experience a weak electrostatic interaction with the same loop via Thr-276 (35) . Finally, the model places the taxoid's C-12 methyl in close proximity to Leu-371 on the B9-B10 loop. Thus, both side chains and baccatin core of the ligand contribute to the scaffold of interactions. Fig.   Fig. 1 . Three PTX conformers docked into the ligand electron crystallographic density of ␤-TB. The first two conformers, a and b, were derived from PTX analogs determined by single-crystal x-ray crystallography. The best-fit conformer, shown in c, was obtained by NMR deconvolution. (Fig. 5c ). The equivalent locus in ␣-TB is occupied by an eight-residue insertion in the loop connecting strands B9 and B10 (Thr-361-Leu-368; see Fig. 4b ). Population of the ␤-TB cleft by Taxol or competitive biomimetics produces protofilaments with a homogeneous face that conceivably contributes to both the formation of MTs by lateral polymerization and to MT stability.
ʈ It likewise suggests the possibility that a properly constituted peptide, endogenous or synthetic, could operate in like manner in PTX's absence.
Structure-Activity Relationships. The model for the PTX-TB complex presented here is in excellent agreement with important elements of the structure-activity relationship data. First, the bioactivity of PTX is relatively insensitive to chemical manipulation from C-7 to C-10 (37). This section of the molecule is not engaged in binding the protein but is projected outward away from the surface of the macromolecule. Second, evidence has accumulated that the C-2Ј hydroxyl is critical for biological activity (38, 39) and is a hydrogen bond donor (40) . In agreement, a hydrogen bond from C-2Ј OH to the backbone carbonyl of Arg-369 exists in the model. Third, replacement of phenyl groups with cyclohexyl moieties in the C-13 and C-2 side chains sustains the activity of PTX (41, 42) . The location of each of the rings in a generous hydrophobic space is compliant. Fourth, extension of the C-4 acetate by longer alkyl chains without loss of activity (43) is explained by the location of the C-4 methyl at the top of a deep hydrophobic cleft. Fifth, meta substitution in the phenyl of the C-2 side-chain enhances activity, whereas para substitution reduces it (44) . The hydrophobic subsite housing this phenyl moiety is relatively tight on three sides of the ring but open at one of the meta positions. The elegant deduction by Horwitz, Kingston, and colleagues that appropriate msubstitution permits the elimination of the C-13 side chain without sacrificing potency or efficacy amplifies the point (33) . Confirming the structural aspects of their work, our model positions the carboxylate of Asp-226 directly above the central cationic nitrogen of the azide in 2-m-azido baccatin. Sixth, C-6 nor-Taxol derivatives drop activity by 10-20 times (45, 46) . Contraction of the C-ring from six members to five pulls the oxetane ring away from Thr-276 and reduces the effectiveness of the O-21͞HN-Thr interaction.
Acquired Resistance. PTX-and epothilone-resistant human ovarian cancer cell lines have been isolated by Giannakakou et al. and shown to express mutant ␤-TB with diminished capacity for TB polymerization by the drugs (47, 48) . The acquired mutations are Phe-2703Val, Ala-3643Thr, Thr-2743Ile, and Arg-2823Gln [corresponding to positions 272, Ser-374, 276, and 284 in the structure-based sequence alignment of ␣-and ␤-TB] (12)].** The first two residues, conferring PTX resistance, line the floor of the deep hydrophobic pocket surrounding the PTX ligand. In the model of Fig. 4a , Phe-272 resides at one end of ␤-sheet strand B7 in van der Waals contact with the methyl group of PTX's C-4 acetate. Ser-374, although not in direct contact with the ligand, is part of a larger hydrophobic cluster that includes Ala-273 and Phe-272. Its replacement by threonine can be viewed as causing a reorganization of the cluster with concomitant adjustment in the position of Phe-272. In this interpretation, both mutations modify the character of the floor of the pocket in a similar manner to effectively block PTX binding. A smaller taxoid surrogate might well escape these changes in protein sequence and stimulate other mutations, as appears to be the case for epothilone. The third and fourth mutations, affording epothilone resistance, are found on the M-loop contiguous with the PTX-binding site (Fig. 4a) . They cause resistance to both PTX and epothilone-driven TB polymerization. From a structural ʈ A protofilament consists of a longitudinal head-to-tail stacking of ␣␤-tubulin dimers. These extended and observable macrostructures are capable of assembling laterally to give cylindrical MTs; see ref. 36 . **The EC structure determination used wild-type pig-brain tubulin with ␤-Ser. Formally, the ␤-Ala-3643 Thr mutation is ␤-Ser-3643 Thr here. point of view, Thr-2763Ile will influence any hydrogen bond between O-21 and threonine, a phenomenon consistent with the resistance shown by a carcinoma subline expressing this ␤-TB mutant (48) . The local electrostatic reorganization does not, however, capture what must be a more subtle effect. Although it has been generally believed that the taxane oxetane ring is ''absolutely required'' for activity, our recent analysis suggests this not to be the case. Both a minireceptor treatment and the complex of Fig. 4a were used to predict that the oxetane ring could be replaced, among others, with a cyclopropane ring without loss in activity (35) . The prediction has been borne out in the Taxotere series in the work of Dubois et al. (49) . Given the uncertainties in the conformation of the M-loop, our model does not provide a specific rationale for the Arg-2843Gln substitution apart from proximity. However, an interesting proposal regarding the disruption of a hydrogen-bonding network mediated by water molecules has been advanced (48).
Photoaffinity Labeling. Photoaffinity-labeling studies distributing photoactive moieties at distant atoms around PTX (i.e., groups at C-2, C-7, and C-3Ј) have successfully identified specific residues in the ␤-TB dimer in close proximity to the binding pocket. Thus, [ 3 H]2-(m-aziodbenzoyl) PTX (AzBo-PTX) photolabels residues 217-231 on and adjacent to helix H7 in ␤-TB (10). Providing perfect consistency, the model nestles the C-2 OCO-Ph ring in a hydrophobic subsite composed of Leu-217, Leu-219, a CH 2 of Asp-226, and His-229 (Fig. 4a) . A second probe, [ 3 H]3Ј-(p-azidobenzamido) PTX (AzBa-PTX), competes with PTX binding and labels the N-terminal 31 amino acids of ␤-TB (6-8). In complete accord, the binding model of Fig. 4a juxtaposes the phenyl ring of C-3Ј NHCO-Ph and the isopropyl group of Val-23 on helix H1. Additionally, the same ring enjoys short contacts with methylene groups (CH 2 ) of Lys-19, Glu-22, and Asp-26. Most recently, a compound that stabilizes MTs in the presence of GTP but does not promote TB polymerization, [
3 H]7-(benzoyldihydro-cinnamoyl) PTX (BzDC-PTX), has been shown to crosslink to ␤Arg-284 (29) . This M-loop residue is the same amino acid that arises from one of the epothilone-resistant cell lines discussed above. Flexible docking of the BzDc-PTX label in the ligand pocket sketched in Fig. 4a effectively superimposes the baccatin core with that of PTX while siting the C-7 benzophenone end-group near ␤Arg-284, as deduced by Ojima, Horwitz, and coworkers (29) . However, the intrusive C-7 side chain has the potential to induce an unnatural M-loop conformation. Thus, our docked BzDC-PTX not only accounts for the labeling of Arg-284 but also suggests a reason for the failure of the photolabel to promote TB polymerization.
Comparison with Other Models. Three recent reports have used the 3.7-Å resolution EC coordinates of ␣␤-TB to derive a proteinbound conformation for either PTX or epothilone (29, 30, 48) . It is important to recall that, whereas the actual TB sheets examined by EC were stabilized by PTX, the deposited protein coordinates contain the single-crystal coordinates for Taxotere in place of the actual ligand (12) [Brookhaven Protein Data Bank (1TUB.pdb)]. All three studies began the PTX-TB model building with the isolated small molecule crystal structure coordinates of either Taxotere or PTX as the starting point, and each ended with essentially the same conformation. By contrast, the PTX model portrayed by Fig. 4a was derived by fitting numerous conformations followed by a treatment that remains fully faithful to the EC density of both the protein and the ligand. Of particular note is the Bane, Kingston, and Schaefer model (30) derived from a combination of solid-state rotational echo double resonance (REDOR) NMR and fluorescence spectroscopy [fluorescence resonance energy transfer (FRET)]. REDOR, performed on labeled and MT-bound PTX, is a conformational determinant permitting measurement of the distance between 19 F at the para-position of the C-2 benzoyl substituent and 13 C at the 3Ј-amide carbonyl and the C-3Ј methine carbons. The values of 9.8 Ϯ 0.5 Å and 10.3 Ϯ 0.5 Å, respectively, led to the choice of the hydrophobically collapsed polar conformation b in Fig. 2 (r calc 9.6 and 10.4 Å, respectively). In good agreement with this measurement, T-Taxol (Fig. 2c) sustains the corresponding distances at 9.1 and 9.9 Å, respectively. Consequently, both structures are viable REDOR candidates, although the intervention of ␤His-229 between the C-2 and C-13 PTX side chains (Figs. 3 and 4a) favors the T-form in the pictured binding mode. FRET, on the other hand, is a ligand orientation probe that depends on the incorporation of both colchicine (COL) and PTX in ␤-TB. To fit the FRET-derived COL-to-PTX distances in the context of the collapsed conformer b, the data were interpreted in terms of an alternative binding mode in which PTX is rotated 180°in the binding pocket relative to the present model. Two factors argue against this binding orientation. First, the polar form in this locus matches the ligand density much less well than that shown in Fig. 1 a and b . Second, the requirement that COL and PTX must simultaneously bind to ␤-TB to derive the PTX-binding mode adds a new variable to the problem. The two antimitotic drugs influence the polymerization of TB in a qualitatively different manner, one destabilizing, the other stabilizing MTs, respectively. Consequently, there is a reasonable possibility that the altered placement of PTX in TB doped by COL results from reorganization of the binding site in the presence of the second drug. As a result, we favor the PTX-only solution in the refined TB coordinates as shown in Figs. 3 and 4a . 
Summary and Conclusions
A model of the bioactive conformation of PTX in its ␤-TBbinding site depicted in Figs. 3 and 4a has been constructed by making maximum use of empirical information and refinement of the EC structure. In short, two dozen conformers of PTX derived from various structural studies were fitted into the partial EC density associated with the ligand in ␤-TB. One of the best solutions was optimized in the binding site by applying computational tools in a way that kept the evolving model fully consistent with the EC density of the protein complex. The final construct, Figs. 3 and 4a , portrays a T-shaped or butterfly Taxol conformation operating as a center of organization for a diversity of secondary structures. Unlike the commonly proposed polar and nonpolar conformations of the drug, which experience intramolecular hydrophobic collapse, T-PTX opens up to permit intermolecular hydrophobic association as seen for the irregularly stacked C-3Ј benzamido, His-229, and C-2 benzoyl moieties. The ligand-protein construct rationalizes a range of structureactivity data involving synthetic substitution at all parts of the PTX molecule. It addresses the issue of drug resistance for several acquired TB mutants in human cancer cells. The new model is in complete harmony with three photoaffinity-labeling studies focused on ␤-TB. By comparing the nearly identical ␣ and ␤ subunits of the ␣␤-TB dimer, we note that PTX in ␤-TB appears to serve a purpose similar to an extended loop in the same location in ␣-TB. The two centers can be viewed as acting in tandem to promote lateral aggregation of TB protofilaments to give mature MTs. Finally, we review the proposals for PTX conformation at the ligand-binding site and argue that the present model incorporates numerous advantages that should prove useful in evaluating and predicting the behavior of taxanes and taxane-mimetic drugs. We also anticipate that the strategy of combining diversity-rich, small-molecule, empirical conformational analysis with 3-4 Å resolution electron crystallography will assist the identification of ligand conformation where partial EC density alone is insufficient to reconcile ambiguities. 
Computational Procedures
Twenty-six paclitaxel (PTX) conformers were derived from x-ray crystal structures or from NMR nuclear Overhauser effect data of PTX and its derivatives (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Side-chain conformations of the taxane structures were retained, but each set of coordinates was modified to give the corresponding PTX structure. Individual conformers were subsequently docked as a rigid body into the experimental density map of the tubulin (TB)-PTX complex. The best fit for each conformation was determined by visual inspection on an SGI O2 workstation by using SYBYL 6.4.2 (http://www.tripos.com) and O 6.1.0 (http://www.imsb.au.dk/~mok/o/). In the complex of αβ-TB fitted with the best conformation of PTX, hydrogens were added to the ligand, and atoms were typed and charged for use with the Kollman all-atom AMBER force field. All subsequent molecular dynamics (MD) and mechanics calculations, with the exception of the FLEXX searches, were run on an SGI POWER CHALLENGE with SYBYL 6.4.1 at the BioMolecular Computing Resource at Emory University. The FLEXX work was performed with SYBYL 6.6.2.
The refined electron crystallography (EC) structure (3.5 Å)* lacks numerous high-energy features found in the unrefined coordinates deposited in the Protein Data Bank (1TUB.pdb). Nonetheless, we desired to produce a relatively strain-free model of the protein--ligand complex. In a first step, all side-chain atoms of the α and β monomers and the PTX ligand (5,275 atoms) were defined as an aggregate, fixing these atoms in coordinate space. In the presence of this aggregate, the remainder of the protein--ligand complex was subjected to 1,000 fs of MD at 20 K with a time step of 0.5 fs, a distancedependent dielectric of 4.5, and an NTV ensemble [i.e., canonical ensemble; constant number of atoms (particles), temperature, and volume]. In a second step, constraints were placed on all main-chain atoms, and the remainder of the protein was allowed to relax by MD for 500 fs. This expedient removes a great majority of nonbonded steric contacts. Contrary to the situation for 1TUB.pdb, no energy-rich hot spots were observed when the MD trajectory was visualized as a video stream. One structure on the latter trajectory around 200 fs was selected for molecular mechanics optimization. The energy of this structure is near the constant low-energy plateau of the trajectory, and it still matches the EC density very well. All atoms outside a 10-Å sphere around PTX in the β-TB-binding site for this complex were defined as an immobile aggregate. Geometry optimization for atoms within the sphere, using the Kollman all-atom force field, was carried to convergence by using a distance-dependent dielectric of 4.5 and an rms gradient energy cutoff of 0.3 kcal. The overall process, which began with a large positive energy, now yields a large negative energy. It should be noted that these MD simulations have been performed at low temperature, in the absence of solvent, and over a time span to prevent a significant rearrangement of the system. Higher temperatures and longer times, without solvation, evolve tubulin structures incompatible with the crystal structure. By using the former conditions, we achieve a strain-free structural model that remains fully faithful to the EC density and the refined coordinates. One measure of the latter is that the final optimized regions of the protein exhibit an excellent fit within the experimental density map. Furthermore, a superposition of the EC-refined β-tubulin and the final optimized subunit (all heavy atoms in the main and side chains) leads to the diminutive rms deviation of 0.47 Å for a total of 3,402 atoms. A similar MD exercise was performed for the α-subunit. We believe the resulting strain-free αβ-TB dimer to be suitable for further modeling studies such as docking and solvated dynamics.
To examine the possible existence of other PTX conformers in the β-TB-binding site, both DOCK (http://www.cmpharm.ucsf.edu/kuntz/ kuntz.html) (11) and FLEXX (12) flexible docking procedures were applied to randomly generate conformations of the ligand. Thus, all heavy-atom torsions within the C-2, C-4, and C-13 side chains of PTX (with the exception of the ester and amide bonds) were explored in the search protocols. For DOCK, the search was performed three times, each run seeded with a different random number. On average, an individual search involves many thousand "tries." A "try" consists of the generation of a new conformation and an attempt to fit it to the binding site. In each PTX case, 2,500 fits were ultimately scored, and the highest-scored 100 docked structures were saved for graphical examination. Only two conformers of PTX were sited in the pocket; the remainder were docked outside or on the periphery of the binding cleft. The lowest energy was the T-form, whereas the other can be described as an uncollapsed "polar" Taxol conformation exhibiting torsional exchange of C-3′ phenyl and C-3′ NHCOPh relative to T-Taxol. However, the latter clearly falls outside the EC ligand density, while simultaneously scoring 45 kcal/mol higher in energy. The FLEXX searches were performed on a TB structure that was allowed to relax for an additional 800 fs of low-temperature MD and allowed to proceed until 200 solutions were achieved. As in the DOCK exercise, the vast majority of the PTX-TB complexes find the ligand outside the binding pocket. In only four cases was Taxol flexibly and successfully fitted to the pocket. The two lowest-energy forms (within 5 kcal/mol of one another) correspond to the T-Taxol conformation. The other two conformers not only did not fit the EC density, but the ligand--protein complexes were ranked with D-score (13) and G-score (14) to be ≈+50 and +100 kcal/mol less stable, respectively, than the lowest energy T-Taxol complex.
